The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study

Neuro Oncol. 2022 Apr 1;24(4):624-638. doi: 10.1093/neuonc/noab210.

Abstract

Background: The role of surgery for incidentally discovered diffuse incidental low-grade gliomas (iLGGs) is debatable and poorly documented in current literature.

Objective: The aim was to identify factors that influence survival for patients that underwent surgical resection of iLGGs in a large multicenter population.

Methods: Clinical, radiological, and surgical data were retrospectively analyzed in 267 patients operated for iLGG from 4 neurosurgical Centers. Univariate and multivariate analyses were performed to identify predictors of overall survival (OS) and tumor recurrence (TR).

Results: The OS rate was 92.41%. The 5- and 10-year estimated OS rates were 98.09% and 93.2%, respectively. OS was significantly longer for patients with a lower preoperative tumor volume (P = .001) and higher extent of resection (EOR) (P = .037), regardless the WHO-defined molecular class (P = .2). In the final model, OS was influenced only by the preoperative tumor volume (P = .006), while TR by early surgery (P = .028). A negative association was found between preoperative tumor volumes and EOR (rs = -0.44, P < .001). The median preoperative tumor volume was 15 cm3. The median EOR was 95%. Total or supratotal resection of T2-FLAIR abnormality was achieved in 61.62% of cases. Second surgery was performed in 26.22%. The median time between surgeries was 5.5 years. Histological evolution to high-grade glioma was detected in 22.85% of cases (16/70). Permanent mild deficits were observed in 3.08% of cases.

Conclusions: This multicenter study confirms the results of previous studies investigating surgical management of iLGGs and thereby strengthens the evidence in favor of early surgery for these lesions.

Keywords: brain mapping; incidental findings; low-grade gliomas; molecular pattern; of resection.

Publication types

  • Multicenter Study

MeSH terms

  • Brain Neoplasms* / pathology
  • Glioma* / pathology
  • Humans
  • Neurosurgical Procedures / methods
  • Retrospective Studies
  • Treatment Outcome